Summary
Cigna Corporation (CI) announced the completion of a significant debt offering, raising $3.5 billion through the issuance of senior notes across various maturities (2030, 2040, and 2050) with coupon rates ranging from 2.400% to 3.400%. This offering was conducted under their existing shelf registration statement. The primary purpose of this financing is to proactively manage and reduce existing debt. Specifically, Cigna intends to use the net proceeds to tender for or redeem approximately $3.5 billion of its existing indebtedness maturing between 2021 and 2023. This includes a tender offer for up to $1.45 billion of notes due in 2022 and 2023, and the redemption of approximately $2.05 billion of notes due in 2021. This strategic refinancing aims to extend the company's debt maturity profile, potentially reduce interest expenses, and enhance financial flexibility. The company has also initiated redemption notices for specific series of its 2021 maturing notes across Cigna Corporation, Cigna Holding Company, and Express Scripts Holding Company.
Key Highlights
- 1Completion of a $3.5 billion senior notes offering across 2030, 2040, and 2050 maturities.
- 2Net proceeds are earmarked for the retirement of approximately $3.5 billion in existing debt maturing between 2021 and 2023.
- 3Initiation of a tender offer for up to $1.45 billion of notes maturing in 2022 and 2023.
- 4Redemption of approximately $2.05 billion of notes maturing in 2021.
- 5Active management of debt structure to optimize maturity profile and potentially reduce interest costs.
- 6Company is undertaking redemption of specific 2021 maturing notes across Cigna Corporation, Cigna Holding Company, and Express Scripts.